• 4172 Citations
  • 32 Scopus h-Index
19992019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Esteban D Braggio is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 32 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Concurrent progressive multifocal leukoencephalopathy and central nervous system infiltration by multiple myeloma: A case report

Ruiz-Heredia, Y., Sanchez-Vega, B., Barrio, S., Linares, M., Rapado, I., Braggio, E. D., Stewart, K., Folgueira, M. D., Ramos, A., Collado, L., Ruiz, J., Toldos, O., Hernandez-Lain, A. & Martinez-Lopez, J., Jun 1 2019, In : Journal of Oncology Pharmacy Practice. 25, 4, p. 998-1002 5 p.

Research output: Contribution to journalArticle

  • 4 Scopus citations

    Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia

    Shanafelt, T. D., Wang, X. V., Kay, N. E., Hanson, C. A., O'Brien, S., Barrientos, J., Jelinek, D. F., Braggio, E., Leis, J. F., Zhang, C. C., Coutre, S. E., Barr, P. M., Cashen, A. F., Mato, A. R., Singh, A. K., Mullane, M. P., Little, R. F., Erba, H., Stone, R. M., Litzow, M. & 1 others, Tallman, M., Aug 1 2019, In : The New England journal of medicine. 381, 5, p. 432-443 12 p.

    Research output: Contribution to journalArticle

  • 52 Scopus citations

    Identification of lenalidomide resistance pathways in myeloma and targeted resensitization using cereblon replacement, inhibition of STAT3 or targeting of IRF4

    Zhu, Y. X., Shi, C. X., Bruins, L. A., Wang, X., Riggs, D. L., Porter, B., Ahmann, J. M., de Campos, C. B., Braggio, E. D., Bergsagel, P. L. & Stewart, A. K., Feb 1 2019, In : Blood cancer journal. 9, 2, 19.

    Research output: Contribution to journalArticle

    Open Access
  • 5 Scopus citations

    IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes

    Fang, H., Reichard, K. K., Rabe, K. G., Hanson, C. A., Call, T. G., Ding, W. D., Kenderian, S., Muchtar, E., Schwager, S. M., Leis, J. F., Chanan Khan, A. A., Slager, S. L., Braggio, E. D., Smoley, S. A., Kay, N. E., Shanafelt, T. D., Van Dyke, D. L. & Parikh, S. A., Jan 1 2019, (Accepted/In press) In : American Journal of Hematology.

    Research output: Contribution to journalArticle

  • 1 Scopus citations

    KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival

    Vendramini, E., Bomben, R., Pozzo, F., Benedetti, D., Bittolo, T., Rossi, F. M., Dal Bo, M., Rabe, K. G., Pozzato, G., Zaja, F., Chiarenza, A., Di Raimondo, F., Braggio, E. D., Parikh, S. A., Kay, N. E., Shanafelt, T. D., Del Poeta, G., Gattei, V. & Zucchetto, A., Jan 1 2019, In : Leukemia.

    Research output: Contribution to journalLetter

    Open Access
    2 Scopus citations